Healthcare >> CEO Interviews >> November 1, 2002
H. PERRY FELL co-founded Seattle Genetics, Inc. in July 1997. He
is the Chairman, Chief Executive Officer and has served on the
Board of Directors since the company's inception. Prior to co-
founding Seattle Genetics, Dr. Fell was with the Bristol-Myers
Squibb Pharmaceutical Research Institute (1986-1997) and directed
the Molecular Immunology Department from 1989-1997. Dr. Fell
received an MBA from the University of Washington, a PhD in
Immunology from the University of Texas Health Science Center at
Dallas, Southwestern Medical School, and a BS in Microbiology
from the University of Texas at Arlington. Dr. Fell has authored
30 scientific papers and holds six patents. Profile
Dr. Fell: Seattle Genetics is a biotechnology company focused on
the use of monoclonal antibodies, principally for the
